Hongmei Su

机构：Guangxi Medical University

发表论文 6 篇 · 总被引 79 次 · h-index 4

代表论文

Isovitexin alleviates hepatic fibrosis by regulating miR-21-mediated PI3K/Akt signaling and glutathione metabolic pathway: based on transcriptomics and metabolomics (2023 · Phytomedicine · 被引 32)
The Integrated Analysis of Transcriptomics and Metabolomics Unveils the Therapeutical Effect of Asiatic Acid on Alcoholic Hepatitis in Rats (2022 · Inflammation · 被引 20)
Isovitexin protects against acute liver injury by targeting PTEN, PI3K and BiP via modification of m6A (2022 · European Journal of Pharmacology · 被引 18)
Association of a Novel DOCK2 Mutation-Related Gene Signature With Immune in Hepatocellular Carcinoma (2022 · Frontiers in Genetics · 被引 5)
Asiatic acid ameliorates rifampicin‐ and isoniazid‐induced liver injury in vivo by regulating sphingolipid metabolism and mitogen‐activated protein kinase signalling pathways (2023 · Basic & Clinical Pharmacology & Toxicology · 被引 4)
The Integrated Analysis of Transcriptomics and Metabolomics Unveils the Therapeutical Effect of Asiatic Acid on Alcoholic Hepatitis in Rats (2021 · Research Square)